Viewing Study NCT02269228


Ignite Creation Date: 2025-12-26 @ 11:13 AM
Ignite Modification Date: 2026-03-04 @ 9:10 AM
Study NCT ID: NCT02269228
Status: COMPLETED
Last Update Posted: 2014-10-21
First Post: 2014-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tolerability of Asasantin in Healthy Female and Male Subjects
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 9.131
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators